Correlation Between Devyser Diagnostics and Sprint Bioscience

Can any of the company-specific risk be diversified away by investing in both Devyser Diagnostics and Sprint Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Devyser Diagnostics and Sprint Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Devyser Diagnostics AB and Sprint Bioscience AB, you can compare the effects of market volatilities on Devyser Diagnostics and Sprint Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Devyser Diagnostics with a short position of Sprint Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Devyser Diagnostics and Sprint Bioscience.

Diversification Opportunities for Devyser Diagnostics and Sprint Bioscience

-0.43

Correlation Coefficient

Devyser Diagnostics  Sprint Bioscience

Very good diversification

The 3 months correlation between Devyser and Sprint is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Devyser Diagnostics AB and Sprint Bioscience AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sprint Bioscience and Devyser Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Devyser Diagnostics AB are associated (or correlated) with Sprint Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sprint Bioscience has no effect on the direction of Devyser Diagnostics i.e., Devyser Diagnostics and Sprint Bioscience go up and down completely randomly.

Pair Corralation between Devyser Diagnostics and Sprint Bioscience

Assuming the 90 days trading horizon Devyser Diagnostics AB is expected to generate 0.43 times more return on investment than Sprint Bioscience. However, Devyser Diagnostics AB is 2.33 times less risky than Sprint Bioscience. It trades about 0.21 of its potential returns per unit of risk. Sprint Bioscience AB is currently generating about -0.04 per unit of risk. If you would invest  10,000  in Devyser Diagnostics AB on April 21, 2025 and sell it today you would earn a total of  3,360  from holding Devyser Diagnostics AB or generate 33.6% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Devyser Diagnostics AB  vs.  Sprint Bioscience AB

Devyser Diagnostics

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Devyser Diagnostics AB are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Devyser Diagnostics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Sprint Bioscience

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sprint Bioscience AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in August 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Devyser Diagnostics and Sprint Bioscience

The main advantage of trading using opposite Devyser Diagnostics and Sprint Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Devyser Diagnostics position performs unexpectedly, Sprint Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sprint Bioscience will offset losses from the drop in Sprint Bioscience's long position.

The idea behind Devyser Diagnostics AB and Sprint Bioscience AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.